Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 10 | 2019 | 55 | 1.900 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 11 | 2019 | 50 | 1.510 |
Why?
|
| Receptors, Thyroid Hormone | 8 | 2015 | 45 | 1.360 |
Why?
|
| Co-Repressor Proteins | 3 | 2015 | 37 | 0.950 |
Why?
|
| Liver | 11 | 2025 | 1763 | 0.940 |
Why?
|
| Nuclear Proteins | 6 | 2017 | 1204 | 0.680 |
Why?
|
| Thyroid Gland | 4 | 2015 | 99 | 0.640 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2017 | 17 | 0.640 |
Why?
|
| Triiodothyronine | 5 | 2014 | 55 | 0.590 |
Why?
|
| Hypothyroidism | 4 | 2017 | 78 | 0.580 |
Why?
|
| Repressor Proteins | 4 | 2009 | 761 | 0.520 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2304 | 0.510 |
Why?
|
| Cholesterol | 4 | 2019 | 535 | 0.470 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2015 | 63 | 0.450 |
Why?
|
| Sulfotransferases | 3 | 2004 | 25 | 0.440 |
Why?
|
| Fructose | 3 | 2021 | 60 | 0.440 |
Why?
|
| Energy Metabolism | 3 | 2019 | 761 | 0.390 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 3 | 2019 | 6 | 0.350 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1377 | 0.350 |
Why?
|
| Animals | 30 | 2025 | 33045 | 0.300 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 3 | 2019 | 31 | 0.280 |
Why?
|
| Lipid Metabolism | 2 | 2025 | 353 | 0.280 |
Why?
|
| Hepatocytes | 2 | 2008 | 231 | 0.270 |
Why?
|
| Mice, Knockout | 9 | 2025 | 3709 | 0.260 |
Why?
|
| Thyroxine | 4 | 2019 | 62 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 5 | 2025 | 1204 | 0.250 |
Why?
|
| Thyrotropin | 4 | 2019 | 53 | 0.250 |
Why?
|
| Protein Binding | 6 | 2015 | 1661 | 0.230 |
Why?
|
| Mice | 19 | 2025 | 17594 | 0.230 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2025 | 270 | 0.210 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 306 | 0.200 |
Why?
|
| Succinic Acid | 1 | 2022 | 13 | 0.190 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 56 | 0.190 |
Why?
|
| Liver X Receptors | 2 | 2014 | 14 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2014 | 17 | 0.180 |
Why?
|
| Systems Analysis | 1 | 2021 | 13 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2023 | 2337 | 0.180 |
Why?
|
| Triglycerides | 2 | 2021 | 596 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 60 | 0.180 |
Why?
|
| Introns | 1 | 2002 | 281 | 0.180 |
Why?
|
| Lipogenesis | 2 | 2018 | 62 | 0.170 |
Why?
|
| Fibroblast Growth Factors | 2 | 2014 | 162 | 0.170 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 114 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 18 | 0.160 |
Why?
|
| Food Deprivation | 1 | 2020 | 34 | 0.160 |
Why?
|
| Glucagon | 1 | 2020 | 146 | 0.160 |
Why?
|
| Exons | 1 | 2002 | 757 | 0.160 |
Why?
|
| Glucosides | 1 | 2020 | 53 | 0.150 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2019 | 10 | 0.150 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 72 | 0.150 |
Why?
|
| Signal Transduction | 6 | 2017 | 4472 | 0.150 |
Why?
|
| Mutation | 5 | 2017 | 5939 | 0.150 |
Why?
|
| Insulin | 2 | 2021 | 1128 | 0.140 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2018 | 9 | 0.140 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2018 | 8 | 0.140 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 8 | 0.140 |
Why?
|
| Glucose | 1 | 2023 | 839 | 0.140 |
Why?
|
| Fructose Intolerance | 1 | 2017 | 3 | 0.140 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 72 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 4502 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3584 | 0.120 |
Why?
|
| Pituitary Gland | 2 | 2014 | 77 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2019 | 1014 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2014 | 160 | 0.120 |
Why?
|
| Gene Expression | 2 | 2011 | 1482 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 132 | 0.120 |
Why?
|
| Body Weight | 1 | 2019 | 970 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 113 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 68 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2015 | 396 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 796 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 191 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 565 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2021 | 2537 | 0.110 |
Why?
|
| Lipotropic Agents | 1 | 2014 | 5 | 0.110 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2014 | 12 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 46 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 452 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2023 | 192 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1479 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 628 | 0.100 |
Why?
|
| Regeneration | 1 | 2015 | 206 | 0.100 |
Why?
|
| Lipids | 4 | 2023 | 550 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 718 | 0.100 |
Why?
|
| Rats | 5 | 2018 | 3387 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 360 | 0.100 |
Why?
|
| Ligands | 2 | 2012 | 477 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 415 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2014 | 144 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 189 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 477 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 754 | 0.100 |
Why?
|
| Retinoid X Receptors | 2 | 2010 | 24 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2014 | 271 | 0.100 |
Why?
|
| Chromatin | 1 | 2015 | 472 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2003 | 251 | 0.100 |
Why?
|
| Cell Line | 4 | 2015 | 2560 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 365 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 622 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2893 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2014 | 321 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 111 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1011 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 1877 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1842 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 449 | 0.080 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2007 | 40 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 53 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 60 | 0.080 |
Why?
|
| Male | 15 | 2025 | 62490 | 0.070 |
Why?
|
| Base Sequence | 2 | 2003 | 2756 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1728 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 279 | 0.070 |
Why?
|
| Species Specificity | 1 | 2009 | 514 | 0.070 |
Why?
|
| Humans | 14 | 2025 | 126679 | 0.070 |
Why?
|
| Tosyl Compounds | 1 | 2007 | 24 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1351 | 0.070 |
Why?
|
| Anilides | 1 | 2007 | 52 | 0.070 |
Why?
|
| Nitriles | 1 | 2007 | 149 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 2004 | 153 | 0.060 |
Why?
|
| Obesity | 1 | 2018 | 2333 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1569 | 0.060 |
Why?
|
| Acetylation | 2 | 2017 | 181 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 58 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 999 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2007 | 402 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2004 | 45 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2541 | 0.060 |
Why?
|
| Adipocytes | 1 | 2006 | 167 | 0.060 |
Why?
|
| Mifepristone | 1 | 2004 | 87 | 0.060 |
Why?
|
| 5' Flanking Region | 1 | 2004 | 9 | 0.060 |
Why?
|
| Nuclear Matrix | 1 | 2004 | 17 | 0.050 |
Why?
|
| Circadian Clocks | 1 | 2025 | 82 | 0.050 |
Why?
|
| Binding Sites | 2 | 2004 | 1185 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 53 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 19 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2003 | 94 | 0.050 |
Why?
|
| Sex Factors | 2 | 2004 | 1309 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 30 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 42 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2882 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 714 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2023 | 191 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 109 | 0.040 |
Why?
|
| Female | 9 | 2025 | 68275 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 784 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2002 | 296 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2002 | 363 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 525 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 73 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1396 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2019 | 24 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 359 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2015 | 551 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 146 | 0.040 |
Why?
|
| Bone Development | 1 | 2019 | 54 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1998 | 9 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 199 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 689 | 0.040 |
Why?
|
| Intestines | 1 | 2022 | 578 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 23 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2310 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 60 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 4 | 0.040 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 59 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 22 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 289 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 305 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 523 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 891 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 377 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 1998 | 311 | 0.030 |
Why?
|
| Bone Density | 1 | 2019 | 351 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 1707 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2746 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2015 | 5 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 986 | 0.030 |
Why?
|
| Xenopus | 1 | 2015 | 103 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 646 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 767 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 90 | 0.030 |
Why?
|
| NAD | 1 | 2015 | 50 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 686 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2020 | 1082 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 100 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 228 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 56 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4426 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 349 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 577 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 2014 | 22 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 502 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 503 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1113 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 84 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 946 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 824 | 0.020 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2012 | 9 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 181 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 4953 | 0.020 |
Why?
|
| Genes, erbA | 1 | 2011 | 1 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4302 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1536 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 210 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 767 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1293 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2011 | 510 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 88 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 971 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 87 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1222 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 365 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6663 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 224 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2006 | 52 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 985 | 0.010 |
Why?
|
| Calcitriol | 1 | 2006 | 62 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2006 | 222 | 0.010 |
Why?
|
| Androgens | 1 | 2007 | 268 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 2004 | 72 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 492 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 658 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1283 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1370 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 20321 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 19987 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 27672 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1758 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 30379 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3497 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6126 | 0.010 |
Why?
|